SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: Cytokine1 who wrote (6417)2/8/1999 11:24:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 9719
 
C1 and Rman:

Yup, nice play with the ENMD short. However, it looks like it may be headed for significantly lower levels.......

prnewswire.com

"Genzyme is the appropriate licensee for this compound," commented Donald
P. Lombardi, director, technology transfer, Children's Hospital, Boston.
"Genzyme possesses the manufacturing and commercialization expertise, the
technical and financial resources, and the willingness to make the needed
strategic commitment to develop this compound."

Rick